IL280868B1 - Compositions and methods for treating acute lung injury - Google Patents

Compositions and methods for treating acute lung injury

Info

Publication number
IL280868B1
IL280868B1 IL280868A IL28086821A IL280868B1 IL 280868 B1 IL280868 B1 IL 280868B1 IL 280868 A IL280868 A IL 280868A IL 28086821 A IL28086821 A IL 28086821A IL 280868 B1 IL280868 B1 IL 280868B1
Authority
IL
Israel
Prior art keywords
compositions
treatment
methods
lung injury
acute lung
Prior art date
Application number
IL280868A
Other languages
English (en)
Hebrew (he)
Other versions
IL280868A (en
Original Assignee
The Trustees Of The Univ Of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of The Univ Of Pennsylvania filed Critical The Trustees Of The Univ Of Pennsylvania
Publication of IL280868A publication Critical patent/IL280868A/en
Publication of IL280868B1 publication Critical patent/IL280868B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL280868A 2018-08-17 2019-08-15 Compositions and methods for treating acute lung injury IL280868B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862719217P 2018-08-17 2018-08-17
PCT/US2019/046698 WO2020037146A1 (en) 2018-08-17 2019-08-15 Compositions and methods for treatment of acute lung injury

Publications (2)

Publication Number Publication Date
IL280868A IL280868A (en) 2021-04-29
IL280868B1 true IL280868B1 (en) 2026-05-01

Family

ID=69524874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL280868A IL280868B1 (en) 2018-08-17 2019-08-15 Compositions and methods for treating acute lung injury

Country Status (11)

Country Link
US (2) US12070483B2 (enExample)
EP (1) EP3836953A4 (enExample)
JP (2) JP7483684B2 (enExample)
KR (1) KR20210046698A (enExample)
CN (1) CN112703009B (enExample)
AU (1) AU2019321654B8 (enExample)
BR (1) BR112021002920A2 (enExample)
CA (1) CA3109798A1 (enExample)
IL (1) IL280868B1 (enExample)
MX (1) MX2021001877A (enExample)
WO (1) WO2020037146A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL280868B1 (en) 2018-08-17 2026-05-01 The Trustees Of The Univ Of Pennsylvania Compositions and methods for treating acute lung injury
KR20260034620A (ko) * 2023-05-05 2026-03-11 페록시테크 인코포레이티드. 패혈성 쇼크 치료용 조성물 및 방법
US20240390452A1 (en) * 2023-05-26 2024-11-28 The Trustees Of The University Of Pennsylvania Protective Agent Against Endothelial Dysfunction

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006301A2 (en) * 2000-06-30 2002-01-24 University Of Cincinnati Peptides with antioxidant and antimicrobial properties

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
ATE173159T1 (de) 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
WO1997047285A1 (en) 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US5972389A (en) 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
US6635280B2 (en) 1997-06-06 2003-10-21 Depomed, Inc. Extending the duration of drug release within the stomach during the fed mode
ES2248908T7 (es) 1997-06-06 2014-11-24 Depomed, Inc. Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
NZ518739A (en) 1999-11-02 2004-12-24 Depomed Inc Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
PT1251832E (pt) 2000-02-04 2007-01-31 Depomed Inc Forma de dosagem constituída por invólucro-e-núcleo que conduz a uma libertação do fármaco de ordem zero
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6451808B1 (en) 2000-10-17 2002-09-17 Depomed, Inc. Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
US20030031711A1 (en) 2001-05-29 2003-02-13 Fara John W. Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
US20030091630A1 (en) 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
JP2005508358A (ja) 2001-10-25 2005-03-31 デポメド・インコーポレイテッド 胃滞留型ロサルタン投与量を用いる治療方法
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
MXPA04010560A (es) * 2002-04-25 2005-08-15 Scripps Research Inst Tratamiento y prevencion de condiciones pulmonares.
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
US9012403B2 (en) * 2010-06-18 2015-04-21 Xiberscience Gmbh Peptides as active agents to stabilize biological barriers
US8962570B2 (en) * 2011-05-17 2015-02-24 University of Pittsburgh—of the Commonwealth System of Higher Education Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism
US11110152B2 (en) * 2016-04-11 2021-09-07 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
IL280868B1 (en) 2018-08-17 2026-05-01 The Trustees Of The Univ Of Pennsylvania Compositions and methods for treating acute lung injury

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006301A2 (en) * 2000-06-30 2002-01-24 University Of Cincinnati Peptides with antioxidant and antimicrobial properties

Also Published As

Publication number Publication date
AU2019321654B1 (en) 2025-07-17
JP7822065B2 (ja) 2026-03-02
US20210315964A1 (en) 2021-10-14
EP3836953A4 (en) 2022-06-29
BR112021002920A2 (pt) 2021-05-11
JP2021534184A (ja) 2021-12-09
CN112703009B (zh) 2024-06-11
US20250082715A1 (en) 2025-03-13
EP3836953A1 (en) 2021-06-23
US12070483B2 (en) 2024-08-27
MX2021001877A (es) 2021-07-15
AU2019321654B8 (en) 2025-08-07
AU2019321654A1 (en) 2021-03-18
WO2020037146A1 (en) 2020-02-20
JP2024102207A (ja) 2024-07-30
KR20210046698A (ko) 2021-04-28
IL280868A (en) 2021-04-29
JP7483684B2 (ja) 2024-05-15
CN112703009A (zh) 2021-04-23
CA3109798A1 (en) 2020-02-20

Similar Documents

Publication Publication Date Title
IL273959A (en) Methods and preparations for the treatment of rare diseases
IL272627A (en) Terpene-enriched cannabinoid compositions and method of treatment
ZA202006610B (en) Compositions for the treatment of skin conditions
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
PL3448421T3 (pl) Sposoby i kompozycje do zapobiegania i leczenia zrostów chirurgicznych
IL272121A (en) Preparation and methods for the treatment of myopia
GB2558021B (en) Composition for treatment and/or nutrition of poultry
IL272937A (en) Preparations and methods for the treatment of diseases involving fibrosis
SG11202012343TA (en) Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegeneration
IL280413A (en) Bismuth-thiol preparations and wound treatment methods
PT3810128T (pt) Composições para tratar e/ou prevenir doenças de agregação de proteinas
IL278978A (en) Preparations and methods for treating eczema
IL276203A (en) Compounds and methods for treating cancer
EP3836953A4 (en) Compositions and methods for treatment of acute lung injury
SG11202002088TA (en) Methods and compositions for treating chronic lung diseases
PT3624812T (pt) Métodos e tratamento de trauma
GB201621737D0 (en) Compositions and methods of treatment
GB201605127D0 (en) Composition and methods of treatment
GB201810923D0 (en) Compositions and method of treatment
SG11202000724XA (en) Methods and compositions for the treatment of cancer
IL280262A (en) Compositions and methods for treating cancer
IL282739A (en) Compounds and methods for treating smooth muscle dysfunction
HK40055609A (en) Compositions and methods for treatment of acute lung injury
IL271564A (en) Preparations for the prevention and treatment of severe kidney damage
SG11202011167YA (en) Air treatment unit and method for treatment of air